We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

CRDO:NASDAQCredo Technology Group Holding Ltd Analysis

Data as of 2026-03-27 - not real-time

$96.44

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Credo posted an earnings beat that sent the stock soaring more than 10% to $114, yet the price has retreated to the $96‑$98 range and now sits well below its 20‑day (108), 50‑day (120) and 200‑day (130) moving averages, indicating a bearish technical backdrop. The RSI sits near 39, suggesting modest oversold pressure, while the MACD histogram remains negative and the volume trend is decreasing, reinforcing short‑term downside risk. Volatility is extreme at roughly 89% over the past month and beta exceeds 2.5, making the share highly sensitive to market swings.
On the fundamentals side, CRDO delivered revenue growth of over 200% YoY, with gross margins near 68% and operating margins above 36%, supported by a strong cash pile of $1.3 bn and minimal debt. The DCF fair‑value estimate of $41 is far below the current market price, and valuation multiples (PE ~53, PB ~9.6) are markedly above industry averages, flagging the stock as overvalued despite a “strong‑buy” consensus from analysts. The business benefits from secular demand in AI‑driven data centers and high‑speed connectivity, but the lofty valuation and heightened market risk temper the upside potential.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Bearish technical indicators (price below all SMAs, negative MACD)
  • Decreasing volume and high short‑term volatility
  • Price approaching the identified support level near $92

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Robust revenue growth and high operating margins
  • Strong cash position with minimal debt
  • Analyst consensus of strong‑buy and overweight ratings

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Secular demand for high‑speed connectivity in AI and data‑center markets
  • Persistent overvaluation relative to DCF fair value
  • Elevated beta and market volatility that could impair long‑run returns

Key Metrics & Analysis

Financial Health

Revenue Growth201.50%
Profit Margin31.81%
P/E Ratio53.0
ROE27.54%
ROA14.68%
Debt/Equity0.88
P/B Ratio9.6
Op. Cash Flow$339.9M
Free Cash Flow$172.2M
Industry P/E32.6

Technical Analysis

TrendBearish
RSI39.0
Support$92.60
Resistance$125.70
MA 20$108.16
MA 50$119.61
MA 200$129.95
MACDBearish
VolumeDecreasing
Fear & Greed Index72.43

Valuation

Fair Value$41.45
Target Price$199.38
Upside/Downside106.73%
GradeOvervalued
TypeGrowth

Risk Assessment

Beta2.51
Volatility89.22%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.